Evaluation of Antipyretic and Anti-inflammatory Activity of Aqueous Extract of <I>Leptadenia Reticulata</I> in Animal Models

<strong>Objective:</strong> To study the antipyretic and anti-inflammatory effects of the Aqueous Extract of <em>Leptadenia Reticulata</em> (AELR) in different animal models. <strong>Materials and Methods</strong>: Acute toxicity studies were performed and extract was found to be safe upto 2000 mg/kg. Two doses were selected for the "evaluation of antipyretic and anti-inflammatory activity of aqueous extract of <em>Leptadenia reticulata</em> in animal models" i.e 200 mg/kg and 400 mg/kg b. w. Antipyretic activity was evaluated using baker's yeast induced pyrexia in albino rats and cow milk induced pyrexia in albino rabbits. Anti-inflammatory activity was evaluated using carrageenan induced paw edema and turpentine oil induced paw edema in albino rats. <strong>Results</strong>: In all the animal models AELR at the dose of 200 mg/kg b.w and 400 mg/kg b.w showed significant (P&lt;0.01) antipyretic and anti-inflammatory activity. <strong>Conclusion</strong>: These finding could justify the inclusion of aqueous extract of <em>Leptadenia reticulata</em> in the management of pyrexia and inflammation.